oa SA Pharmaceutical Journal - Fixed-combination inhalers for asthma and chronic obstructive pulmonary disease : review
Differentiating between asthma and chronic obstructive pulmonary disease (COPD) remains clinically challenging, but is essential for the appropriate management and optimisation of clinical outcomes in patients. In many countries, the majority of patients are prescribed long-acting, inhaled β2-agonists and inhaled corticosteroids as maintenance treatment for asthma and COPD. Compliance with these medications is often poor, particularly in the case of inhaled corticosteroids, as these medicines do not provide immediate relief from symptoms. Various studies have concluded that patients prefer using fixed-combination inhalers and that these treatments may improve compliance and achieve better disease control.
Article metrics loading...